Love is blind, the saying goes, and thanks to a world-first Australian study, we are now a step closer to understanding why.
New treatment option for endometrial cancer shows promise in phase II trial
The latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanced or recurrent endometrial cancer moves